Moderna CEO Bancel amends 10b5-1 plan to exercise 4.6M options; expects to donate $355M proceeds

Moderna, Inc.

CEO Bancel amended 10b5-1 plan to exercise 4,587,155 shares at $0.99/share (option from 2013, expiring Aug 2023).
Exercise schedule: 40,000 shares each Wednesday and Thursday starting May 25, 2022, until fully exercised.
After-tax proceeds (~$355M at ~$140/sh) to be donated to charity; ~$280M in taxes paid.
Bancel's family entity OCHA LLC continues selling 10,000 shares each Thursday under separate 10b5-1 plan through end of 2022.
Bancel terminated prior 10b5-1 plans for gifts/sales in March 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.